FOLD Q2 2020 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$62M+41.3% YoY

Gross Profit

$56M89.3% margin

Operating Income

-$51M-82.3% margin

Net Income

-$52M-84.2% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+3.0%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$35M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$701M

Total Liabilities

$340M

Stockholders' Equity

$361M

Cash & Equivalents

$165M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$44M	+41.3%
Gross Profit	$56M	$39M	+43.6%
Operating Income	-$51M	-$76M	+32.8%
Net Income	-$52M	-$85M	+37.9%

Geographic Segments

Non-US

$42M67%

UNITED STATES

$21M33%